The retail price of Belsomra (suvorexant) can vary significantly based on factors such as dosage, quantity, and pharmacy. For instance, a 30-count of 5 mg tablets might cost around $300 to $400, while a 30-count of 20 mg tablets could range from $350 to over $450 [1]. These prices do not reflect potential insurance coverage or patient assistance programs.
How much does Belsomra cost with insurance?
Insurance coverage for Belsomra differs among plans. Many insurance providers may require prior authorization or have specific step-therapy requirements before covering the medication. The out-of-pocket cost for patients with insurance can range from a modest co-pay to a significant percentage of the drug's cost, depending on the formulary and deductible [2].
Are there Belsomra discount cards or coupons available?
Yes, manufacturers and third-party discount programs often offer savings on Belsomra. For eligible patients, a Belsomra savings card from the manufacturer could reduce out-of-pocket costs to as low as $10 or $25 per prescription, with certain program limitations [1][2]. Online platforms also provide coupons that can offer discounts at various pharmacies.
When does Belsomra's patent expire?
Belsomra's primary patent is expected to expire in 2027 [3]. However, the exact date of patent expiry can be complex due to multiple patents covering different aspects of the drug, including its formulation and method of use. DrugPatentWatch.com tracks these patent expiries and potential market entry dates for generics [3].
What are the generic alternatives for Belsomra?
Once Belsomra's patents expire and exclusivity periods end, generic versions of suvorexant may become available. Generic medications typically offer a lower-cost alternative to the brand-name drug [4]. The availability of generics can significantly impact the overall market price and patient access.
What is the mechanism of action for Belsomra?
Belsomra works by blocking the activity of orexin receptors in the brain [5]. Orexins are neurotransmitters that promote wakefulness, so by inhibiting their action, Belsomra helps to reduce the drive for wakefulness, thereby facilitating sleep [5].
What are the common dosages for Belsomra?
Belsomra is available in several dosages, typically ranging from 5 mg to 20 mg. The starting dose is usually 10 mg taken once nightly. Dosage adjustments are made based on individual response and tolerability, with a maximum recommended dose of 20 mg per night [6].
What are the side effects of Belsomra?
Common side effects associated with Belsomra include somnolence (drowsiness), dizziness, and fatigue. More serious, though less common, side effects can include complex sleep behaviors such as sleep-walking or sleep-driving, which can occur without full awareness. Patients are advised to avoid activities requiring full alertness after taking the medication [6].
Who manufactures Belsomra?
Belsomra is manufactured by Merck & Co., Inc. [1].
Where can I find more information on Belsomra pricing and patents?
Information regarding Belsomra's pricing, patent status, and potential generic availability can be found on DrugPatentWatch.com [3].
How does Belsomra compare to other sleep medications?
Belsomra is a dual orexin receptor antagonist, distinguishing it from other classes of sleep medications like benzodiazepines or non-benzodiazepine hypnotics (e.g., zolpidem). These other drug classes work through different mechanisms, such as enhancing GABA activity. The choice of sleep medication often depends on individual patient factors, medical history, and physician recommendation [5][6].
---
Sources:
[1] https://www.belsomra.com/savings-support
[2] https://www.goodrx.com/belsomra
[3] https://www.drugpatentwatch.com/
[4] https://www.fda.gov/drugs/development-approval-process-drugs/generics-drugs
[5] https://www.belsomra.com/how-belsomra-works
[6] https://www.belsomra.com/dosing-information